| HOME >> BIOLOGY >> TECHNOLOGY |
REFERENCES
1. Zambon, A. C., L. L. Brunton, K. E. Barrett, R. J. Hughes, B. Torres, and P. A. Insel. 2001. Cloning, expression, signaling mechanisms and membrane targeting of P2Y11 receptors in cultured MDCK-D1 cells. Mol. Pharmacol. 60: 2635.
2. Communi, D., R. Janssens, N. Suarez-Huerta, B. Robaye, and J. M. Boeynaems. 2000. Advances in signalling by extracellular nucleotides. The role and transduction mechanisms of P2Y receptors. Cell Signal. 12: 351360.
3. von Kugelgen, I., and A. Wetter. 2000. Molecular pharmacology of P2Yreceptors. Naunyn Schmiedebergs Arch. Pharmacol. 362: 310323.
4. Communi, D., C. Govaerts, M. Parmentier, and J. M. Boeynaems. 1997. Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J. Biol. Chem. 272: 3196931973.
5. Communi, D., B. Robaye, and J. M. Boeynaems. 1999. Pharmacological characterization of the human P2Y11 receptor. Br. J. Pharmacol. 128: 11991206.
6. van der Weyden, L., A. D. Conigrave, and M. B. Morris. 2000. Signal transduction and white cell maturation via extracellular ATP and the P2Y11 receptor. Immunol. Cell. Biol. 78: 369374.
7. van der Weyden, L., D. J. Adams, and B. J. Morris. 2000. Capacity for purinergic control of renin promoter via P2Y(11) receptor and cAMP pathways. Hypertension 36: 10931098.
8. Communi, D., R. Janssens, B. Robaye, N. Zeelis, and J. M. Boeynaems. 2000. FEBS Letters 475: 3942.
9. Post, S. R., L. C. Rump, A. Zambon, R. J. Hughes, M. D. Buda, J. P. Jacobson, C. C. Kao, and P. A. Insel. 1998. ATP activates cAMP produc
'"/>
Source: